Published in Am J Kidney Dis on November 01, 2009
Intradialytic hypertension is a marker of volume excess. Nephrol Dial Transplant (2010) 1.09
The effect of empowerment on the self-efficacy, quality of life and clinical and laboratory indicators of patients treated with hemodialysis: a randomized controlled trial. Health Qual Life Outcomes (2012) 1.04
Blood pressure measurement: clinic, home, ambulatory, and beyond. Am J Kidney Dis (2012) 0.94
Postdialysis blood pressure rise predicts long-term outcomes in chronic hemodialysis patients: a four-year prospective observational cohort study. BMC Nephrol (2012) 0.92
Effect of lisinopril and atenolol on aortic stiffness in patients on hemodialysis. Clin J Am Soc Nephrol (2015) 0.87
Toward a definition of masked hypertension and white-coat hypertension among hemodialysis patients. Clin J Am Soc Nephrol (2011) 0.83
Ambulatory aortic blood pressure, wave reflections and pulse wave velocity are elevated during the third in comparison to the second interdialytic day of the long interval in chronic haemodialysis patients. Nephrol Dial Transplant (2015) 0.78
Ambulatory recording of wave reflections and arterial stiffness during intra- and interdialytic periods in patients treated with dialysis. Clin J Am Soc Nephrol (2015) 0.78
Relative Importance of Aortic Stiffness and Volume as Predictors of Treatment-Induced Improvement in Left Ventricular Mass Index in Dialysis. PLoS One (2015) 0.75
K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis (2005) 6.31
Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials. Lancet (2009) 4.73
Achieving blood pressure targets during dialysis improves control but increases intradialytic hypotension. Kidney Int (2007) 3.84
"U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. Kidney Int (1998) 3.53
Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis (1999) 3.09
Cardiovascular protection with antihypertensive drugs in dialysis patients: systematic review and meta-analysis. Hypertension (2009) 2.97
Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension (2008) 2.96
Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med (2003) 2.94
Pre- and postdialysis blood pressures are imprecise estimates of interdialytic ambulatory blood pressure. Clin J Am Soc Nephrol (2006) 2.27
Hypertension and survival in chronic hemodialysis patients--past lessons and future opportunities. Kidney Int (2005) 2.25
The epidemiology of systolic blood pressure and death risk in hemodialysis patients. Am J Kidney Dis (2006) 2.22
Physiological changes during hemodialysis in patients with intradialysis hypertension. Kidney Int (2006) 2.12
Out-of-hemodialysis-unit blood pressure is a superior determinant of left ventricular hypertrophy. Hypertension (2005) 1.98
Home blood pressure monitoring improves the diagnosis of hypertension in hemodialysis patients. Kidney Int (2006) 1.88
Home blood pressures are of greater prognostic value than hemodialysis unit recordings. Clin J Am Soc Nephrol (2007) 1.76
Home blood pressure measurements for managing hypertension in hemodialysis patients. Am J Nephrol (2009) 1.71
Trended cosinor change model for analyzing hemodynamic rhythm patterns in hemodialysis patients. Hypertension (2007) 1.39
Association of blood pressure increases during hemodialysis with 2-year mortality in incident hemodialysis patients: a secondary analysis of the Dialysis Morbidity and Mortality Wave 2 Study. Am J Kidney Dis (2009) 1.39
Relationships of N-terminal pro-B-natriuretic peptide and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients. Am J Kidney Dis (2007) 1.38
Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patients. Am J Kidney Dis (2007) 1.32
The role of ambulatory blood pressure monitoring in chronic and end-stage renal disease. Kidney Int (2006) 1.26
Diagnosing hypertension by intradialytic blood pressure recordings. Clin J Am Soc Nephrol (2008) 1.18
Reproducibility of ambulatory blood pressure monitoring in hemodialysis patients. Am J Kidney Dis (2000) 1.16
Age-related blood pressure patterns and blood pressure variability among hemodialysis patients. Clin J Am Soc Nephrol (2008) 1.13
Location not quantity of blood pressure measurements predicts mortality in hemodialysis patients. Am J Nephrol (2007) 1.13
Arterial stiffness and interdialytic weight gain influence ambulatory blood pressure patterns in hemodialysis patients. Am J Physiol Renal Physiol (2007) 1.06
The association between blood pressure and mortality in ESRD-not different from the general population? Semin Dial (2007) 1.06
Volume-associated ambulatory blood pressure patterns in hemodialysis patients. Hypertension (2009) 1.02
Exploring the paradoxical relationship of hypertension with mortality in chronic hemodialysis. Hemodial Int (2004) 0.98
Circadian blood pressure: clinical implications based on the pathophysiology of its variability. Kidney Int (2007) 0.94
Systolic hypertension in hemodialysis patients. Semin Dial (2003) 0.92
Role of home blood pressure monitoring in hemodialysis patients. Am J Kidney Dis (1999) 0.92
How should hypertension be assessed and managed in hemodialysis patients? Home BP, not dialysis unit BP, should be used for managing hypertension. Semin Dial (2007) 0.88
Validation of the SpaceLabs 90207 ambulatory blood pressure device for hemodialysis patients. Blood Press Monit (1999) 0.88
Hypertension is harmful to dialysis patients and should be controlled. Semin Dial (2007) 0.86
Chronobiology of arterial hypertension in hemodialysis patients: implications for home blood pressure monitoring. Am J Kidney Dis (2009) 0.86
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet (2010) 7.69
Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. JAMA (2012) 5.27
Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial. Hypertension (2008) 2.99
Cardiovascular protection with antihypertensive drugs in dialysis patients: systematic review and meta-analysis. Hypertension (2009) 2.97
Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease. Am Heart J (2012) 2.42
Platelet glycoprotein IIb/IIIa inhibition using eptifibatide with primary coronary stenting for acute myocardial infarction: a 30-day follow-up study. Catheter Cardiovasc Interv (2002) 2.07
Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch Intern Med (2011) 2.06
Prevalence and prognostic role of resistant hypertension in chronic kidney disease patients. J Am Coll Cardiol (2013) 1.97
Relative plasma volume monitoring during hemodialysis AIDS the assessment of dry weight. Hypertension (2009) 1.87
Home blood pressures are of greater prognostic value than hemodialysis unit recordings. Clin J Am Soc Nephrol (2007) 1.76
Short-term vitamin D receptor activation increases serum creatinine due to increased production with no effect on the glomerular filtration rate. Kidney Int (2011) 1.73
A longitudinal study of kidney structure and function in adults. Nephrol Dial Transplant (2009) 1.63
A double-blind randomized crossover trial of two loop diuretics in chronic kidney disease. Kidney Int (2003) 1.40
Trended cosinor change model for analyzing hemodynamic rhythm patterns in hemodialysis patients. Hypertension (2007) 1.39
Relationships of N-terminal pro-B-natriuretic peptide and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients. Am J Kidney Dis (2007) 1.38
Newly developed techniques to study and diagnose acute renal failure. J Am Soc Nephrol (2003) 1.38
A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKD. Am J Kidney Dis (2006) 1.38
Analyzing change: a primer on multilevel models with applications to nephrology. Am J Nephrol (2008) 1.36
Home blood pressure monitoring in CKD. Am J Kidney Dis (2005) 1.34
Masked hypertension and white-coat hypertension in chronic kidney disease: a meta-analysis. Clin J Am Soc Nephrol (2009) 1.26
Rationale and trial design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON). Am J Nephrol (2013) 1.23
Pulmonary hypertension in CKD. Am J Kidney Dis (2012) 1.19
Assessment of blood pressure in hemodialysis patients. Semin Dial (2002) 1.15
Wellens syndrome: a life-saving diagnosis. Am J Emerg Med (2010) 1.15
Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran. Kidney Int (2002) 1.15
Hyporesponsiveness to erythropoietin: causes and management. Adv Chronic Kidney Dis (2009) 1.12
Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients. Kidney Int (2003) 1.11
Can chronic volume overload be recognized and prevented in hemodialysis patients? The pitfalls of the clinical examination in assessing volume status. Semin Dial (2009) 1.10
Cardiomyocyte lipids impair β-adrenergic receptor function via PKC activation. Am J Physiol Endocrinol Metab (2010) 1.09
Statin induced proteinuria: renal injury or renoprotection? J Am Soc Nephrol (2004) 1.09
KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD. Am J Kidney Dis (2013) 1.08
Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial. Nephrol Dial Transplant (2014) 1.07
Chronic kidney disease as a coronary disease equivalent--a comparison with diabetes over a decade. Clin J Am Soc Nephrol (2011) 1.02
New therapies from old medicines. Nat Biotechnol (2008) 0.99
Acute injury with intravenous iron and concerns regarding long-term safety. Clin J Am Soc Nephrol (2006) 0.96
Home blood pressure monitoring: how good a predictor of long-term risk? Curr Hypertens Rep (2011) 0.95
Role of excess volume in the pathophysiology of hypertension in chronic kidney disease. Kidney Int (2003) 0.95
Role of oxidative stress in diabetic nephropathy. Adv Chronic Kidney Dis (2005) 0.93
Hypertension, hypokalemia, and thiazide-induced diabetes: a 3-way connection. Hypertension (2008) 0.93
Systolic hypertension in hemodialysis patients. Semin Dial (2003) 0.92
Etiology and management of hypertension in chronic kidney disease. Med Clin North Am (2005) 0.92
Appropriateness of antihypertensive drug therapy in hemodialysis patients. Clin J Am Soc Nephrol (2006) 0.91
Bullying in schools: prevalence and short-term impact. Indian Pediatr (2007) 0.91
Proteinuria and endothelial dysfunction in stable HIV-infected patients. A pilot study. J Acquir Immune Defic Syndr (2007) 0.91
Accuracy of oscillometric blood pressure monitoring with concurrent auscultatory blood pressure in hemodialysis patients. Blood Press Monit (2005) 0.90
Iron, oxidative stress, and clinical outcomes. Pediatr Nephrol (2007) 0.90
Racial difference in the activity of the amiloride-sensitive epithelial sodium channel. Hypertension (2002) 0.87
Vitamin D receptor activation and left ventricular hypertrophy in advanced kidney disease. Am J Nephrol (2011) 0.87
Sodium ferric gluconate causes oxidative stress but not acute renal injury in patients with chronic kidney disease: a pilot study. Nephrol Dial Transplant (2004) 0.86
The use of group sequential, information-based sample size re-estimation in the design of the PRIMO study of chronic kidney disease. Clin Trials (2011) 0.86
Hypertension is harmful to dialysis patients and should be controlled. Semin Dial (2007) 0.86
Neither proteinuria nor albuminuria is associated with endothelial dysfunction in HIV-infected patients without diabetes or hypertension. J Infect Dis (2011) 0.84
Chlorthalidone for poorly controlled hypertension in chronic kidney disease: an interventional pilot study. Am J Nephrol (2014) 0.84
Resistant hypertension and the neglected antihypertensive: sodium restriction. Nephrol Dial Transplant (2012) 0.84
Proteinuria and hypertension with tyrosine kinase inhibitors. Kidney Int (2011) 0.83
Thiazide diuretics in advanced chronic kidney disease. J Am Soc Hypertens (2012) 0.83
Toward a definition of masked hypertension and white-coat hypertension among hemodialysis patients. Clin J Am Soc Nephrol (2011) 0.83
Chronic use of sodium ferric gluconate complex in hemodialysis patients: safety of higher-dose (> or =250 mg) administration. Am J Kidney Dis (2003) 0.83
Diagnosis and Treatment of Sleep Apnea in patients' homes: the rationale and methods of the "GoToSleep" randomized-controlled trial. J Clin Sleep Med (2012) 0.82
Rationale, design, and baseline characteristics of ARTS-DN: a randomized study to assess the safety and efficacy of finerenone in patients with type 2 diabetes mellitus and a clinical diagnosis of diabetic nephropathy. Am J Nephrol (2015) 0.81
Improving outcomes in CKD and ESRD patients: carrying the torch from training to practice. Semin Dial (2004) 0.81
Norian craniofacial repair system: compatibility with resorbable and nonresorbable plating materials. Plast Reconstr Surg (2007) 0.81
Shorter delivered dialysis times associate with a higher and more difficult to treat blood pressure. Nephrol Dial Transplant (2013) 0.81
Benefits of and barriers to dietary sodium adherence. West J Nurs Res (2006) 0.81
Safety and efficacy of sodium ferric gluconate complex in patients with chronic kidney disease. Am J Kidney Dis (2002) 0.80
Current and future application of genetic toxicity assays: the role and value of in vitro mammalian assays. Toxicol Sci (2009) 0.80
Drug insight: Safety of intravenous iron supplementation with sodium ferric gluconate complex. Nat Clin Pract Nephrol (2006) 0.79
Ironing out the mystery of nephrotoxicity of parenteral iron. J Lab Clin Med (2005) 0.79
Volume overload in dialysis: the elephant in the room, no one can see. Am J Nephrol (2013) 0.79
Use of dried plasma spots for the quantification of iothalamate in clinical studies. Clin J Am Soc Nephrol (2013) 0.79
Should all hypertensive dialysis patients receive a blocker of the Renin-Angiotensin system? Curr Hypertens Rep (2010) 0.78
Interpreting results of clinical trials: a conceptual framework. Clin J Am Soc Nephrol (2008) 0.78
Proteinuria is a determinant of quality of life in diabetic nephropathy: modeling lagged effects with path analysis. Am J Nephrol (2007) 0.77
Estimating GFR from serum creatinine concentration: pitfalls of GFR-estimating equations. Am J Kidney Dis (2005) 0.77
Prevalence of left ventricular hypertrophy: some alternate thoughts. Am J Kidney Dis (2005) 0.77
Chronic renal disease progression: treatment strategies and potassium intake. Semin Nephrol (2013) 0.77
Thiazide Diuretics in Chronic Kidney Disease. Curr Hypertens Rep (2015) 0.76
Frequent versus standard hemodialysis. N Engl J Med (2011) 0.76
Determinants and short-term reproducibility of relative plasma volume slopes during hemodialysis. Clin J Am Soc Nephrol (2012) 0.76
Epidemiology of chronic kidney disease among normotensives: but what is chronic kidney disease? Hypertension (2010) 0.76
Adverse effects of conventional thrice-weekly hemodialysis: is it time to avoid 3-day interdialytic intervals? Am J Nephrol (2015) 0.76
Renal failure in cirrhosis: is it time to change the diagnosis and classification? Am J Nephrol (2013) 0.76
The unrecognized skeletal components of the cleft lip nose deformity. Plast Reconstr Surg (2008) 0.75
ACP Journal Club. Use of ≥ 1 antihypertensive drug at bedtime reduced CV events more than use of all drugs in the morning in CKD. Ann Intern Med (2012) 0.75
Arrhythmogenic right ventricular dysplasia: initial presentation in a middle-aged woman. Tex Heart Inst J (2006) 0.75
Ambulatory blood pressure monitoring trumps estimated glomerular filtration rate in predicting cardiovascular risk in low-risk populations. Hypertension (2012) 0.75
Anthropometric evaluation of complete unilateral cleft lip nose with cone beam CT in early childhood. J Plast Reconstr Aesthet Surg (2011) 0.75
Meta-analysis-not proof but call for action. Hypertension (2009) 0.75
Home BP for assessing haemodialysis hypertension. Nephrol Dial Transplant (2007) 0.75
What are the causes of the ill effects of chronic hemodialysis? The fallacy of low interdialytic weight gain and low ultrafiltration rate: lower is not always better. Semin Dial (2013) 0.75
What can we learn from null randomized controlled trials? J Am Soc Nephrol (2013) 0.75
A novel cleft rhinoplasty procedure combining an open rhinoplasty with the Dibbell and Tajima techniques. Plast Reconstr Surg (2010) 0.75
Combination therapy of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chronic kidney disease. F1000 Med Rep (2009) 0.75
Thiazide and thiazide-like diuretics: perspectives on individualization of drug and dose based on therapeutic index. Hypertension (2012) 0.75
Relative plasma volume monitoring for identifying volume-sensitive and -resistant hypertension. Semin Dial (2010) 0.75
Efficacy and safety of ibutilide for chemical cardioversion of atrial fibrillation and atrial flutter in cancer patients. Am J Med Sci (2014) 0.75